Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.

The nominee for HHS secretary hedged this answers to questions about vaccine safety and efficacy at his second confirmation hearing today.

Some regulatory changes are already set to happen this year, but reduced regulation under the new administration could have a ripple effects in healthcare. Meanwhile, artificial intelligence is likely ...

The Cigna Group reported today their total revenue of $247.1 billion for 2024, compared with $195.3 billion in 2023. This growth highlights the company’s strong financial results, supported by ...

After several days of worry that the global AIDS program might come to abrupt end, Secretary of State Marco Rubio issued a ...

At today's confirmation hearing, Democratic senators were skeptical of the HHS Secretary nominee Robert F. Kennedy Jr.'s ...

Robert F. Kennedy Jr., the HHS secretary nominee, has said he is not antivaccine, but he has a track record of casting doubt ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

The survey also showed that high drug costs and artificial intelligence are topmost among the respondent’s concerns.

In this new role, Flaster will lead Cigna Healthcare’s clinical organization, focusing on initiatives to improve customer ...

Panelists discuss the potential role of emerging treatments in the progressive pulmonary fibrosis (PPF) landscape if approved ...